CoChat

Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery

Open access

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Abstract

Realizing the full potential of genome editing requires the development of efficient and broadly applicable methods for delivering programmable nucleases and donor templates for homology-directed repair (HDR). The RNA-guided Cas9 endonuclease can be introduced into cells as a purified protein in complex with a single guide RNA (sgRNA). Such ribonucleoproteins (RNPs) can facilitate the high-fidelity introduction of single-base substitutions via HDR following co-delivery with a single-stranded DNA oligonucleotide. However, combining RNPs with transgene-containing donor templates for targeted gene addition has proven challenging, which in turn has limited the capabilities of the RNP-mediated genome editing toolbox. Here, we demonstrate that combining RNP delivery with naturally recombinogenic adeno-associated virus (AAV) donor vectors enables site-specific gene insertion by homology-directed genome editing. Compared to conventional plasmid-based expression vectors and donor templates, we show that combining RNP and AAV donor delivery increases the efficiency of gene addition by up to 12-fold, enabling the creation of lineage reporters that can be used to track the conversion of striatal neurons from human fibroblasts in real time. These results thus illustrate the potential for unifying nuclease protein delivery with AAV donor vectors for homology-directed genome editing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkx154

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Combining Cas9 ribonucleoprotein (RNP) and adeno-associated virus (AAV) donor delivery facilitates gene correction in HEK293T cells. (A) Schematic representation of the GFP reporter system. Lightning bolt indicates approximate position of the RNP cleavage site. The sgRNA target site in GFPΔ35 is shown. Abbreviations are as follows: ITR, inverted terminal repeat; IRES, internal ribosome entry site; LTR, long terminal repeat; UbC, ubiquitin C promoter; PAM, protospacer adjacent motif. (B) Cartoon illustrating RNP and AAV delivery to cells synchronized at G2/M phase. (C) Percentage of GFP positive HEK293T reporter cells following delivery of different combinations of plasmid donor (800 ng), Cas9–sgRNA expression vector (800 ng), AAV donor (multiplicity of infection [MOI] = 100 000) and RNP (300 pmol). (D) Percentage of GFP positive reporter cells following treatment with RNP (300 pmol) and AAV donor (MOI = 100 000) in the presence or absence of 200 ng/ml nocodazole. (E and F) Percentage of GFP positive reporter cells following treatment with (E) increasing amounts of RNP and AAV donor or (F) RNP (300 pmol) and AAV donor (MOI = 100 000) in the presence or absence of 1 μM Scr7. In all cases, AAV donor was added to cells 16 h before RNP delivery. All cells were treated with 200 ng/ml of nocodazole unless otherwise indicated. Values are means (n = 3) and error bars indicate S.D. ***P < 0.0005; unpaired t-tests.
Figure 1. Combining Cas9 ribonucleoprotein (RNP) and adeno-associated virus (AAV) donor delivery facilitates gene correction in HEK293T cells. (A) Schematic representation of the GFP reporter system. Lightning bolt indicates approximate position of the RNP cleavage site. The sgRNA target site in GFPΔ35 is shown. Abbreviations are as follows: ITR, inverted terminal repeat; IRES, internal ribosome entry site; LTR, long terminal repeat; UbC, ubiquitin C promoter; PAM, protospacer adjacent motif. (B) Cartoon illustrating RNP and AAV delivery to cells synchronized at G2/M phase. (C) Percentage of GFP positive HEK293T reporter cells following delivery of different combinations of plasmid donor (800 ng), Cas9–sgRNA expression vector (800 ng), AAV donor (multiplicity of infection [MOI] = 100 000) and RNP (300 pmol). (D) Percentage of GFP positive reporter cells following treatment with RNP (300 pmol) and AAV donor (MOI = 100 000) in the presence or absence of 200 ng/ml nocodazole. (E and F) Percentage of GFP positive reporter cells following treatment with (E) increasing amounts of RNP and AAV donor or (F) RNP (300 pmol) and AAV donor (MOI = 100 000) in the presence or absence of 1 μM Scr7. In all cases, AAV donor was added to cells 16 h before RNP delivery. All cells were treated with 200 ng/ml of nocodazole unless otherwise indicated. Values are means (n = 3) and error bars indicate S.D. ***P < 0.0005; unpaired t-tests.CC BY-NC · PubMed Central
Figure 2. Gene correction in U2OS following RNP and AAV donor delivery. (A and B) Percentage of GFP positive reporter cells following treatment with (A) RNP (300 pmol) and increasing amounts of AAV donor or (B) RNP (300 pmol) and AAV donor (MOI = 100 000) in the presence or absence of 1 μM Scr7. AAV donor was added to cells 16 h before RNP delivery. All cells were treated with 200 ng/ml of nocodazole. Values are means (n = 3) and error bars indicate S.D.
Figure 2. Gene correction in U2OS following RNP and AAV donor delivery. (A and B) Percentage of GFP positive reporter cells following treatment with (A) RNP (300 pmol) and increasing amounts of AAV donor or (B) RNP (300 pmol) and AAV donor (MOI = 100 000) in the presence or absence of 1 μM Scr7. AAV donor was added to cells 16 h before RNP delivery. All cells were treated with 200 ng/ml of nocodazole. Values are means (n = 3) and error bars indicate S.D.CC BY-NC · PubMed Central
Figure 3. EGFP knock-in into the rat nestin locus via RNP and AAV donor delivery. (A) Schematic representation of the strategy used to tag the rat nestin gene with EGFP. Lightning bolt indicates approximate position of the RNP cleavage site. The sgRNA target site in the nestin gene is shown. Abbreviations are as follows: ITR, inverted terminal repeat; HA, homology arm; CMV, cytomegalovirus promoter; PAM, protospacer adjacent motif. (B) Percentage of GFP positive rat C6 cells measured by flow cytometry following delivery of different combinations of plasmid donor (800 ng), Cas9–sgRNA expression vector (800 ng), AAV donor (MOI = 100 000) and RNP (300 pmol) in the presence or absence of 1 μM Scr7. AAV donor was added to cells 16 h prior to RNP delivery. All cells were treated with 200 ng/ml of nocodazole. Values are means (n = 3) and error bars indicate S.D. ***P < 0.0005; unpaired t-tests.
Figure 3. EGFP knock-in into the rat nestin locus via RNP and AAV donor delivery. (A) Schematic representation of the strategy used to tag the rat nestin gene with EGFP. Lightning bolt indicates approximate position of the RNP cleavage site. The sgRNA target site in the nestin gene is shown. Abbreviations are as follows: ITR, inverted terminal repeat; HA, homology arm; CMV, cytomegalovirus promoter; PAM, protospacer adjacent motif. (B) Percentage of GFP positive rat C6 cells measured by flow cytometry following delivery of different combinations of plasmid donor (800 ng), Cas9–sgRNA expression vector (800 ng), AAV donor (MOI = 100 000) and RNP (300 pmol) in the presence or absence of 1 μM Scr7. AAV donor was added to cells 16 h prior to RNP delivery. All cells were treated with 200 ng/ml of nocodazole. Values are means (n = 3) and error bars indicate S.D. ***P < 0.0005; unpaired t-tests.CC BY-NC · PubMed Central
Figure 4. AAV-RNP-mediated knock-in of EGFP into the human DARPP-32 locus enables induced striatal neurons to be visualized via EGFP fluorescence. (A) Cartoon representation of the strategy used to tag the human DARPP-32 gene with EGFP. Lightning bolt indicates approximate position of the RNP cleavage site. The sgRNA target site in the DARPP-32 gene is shown. Abbreviations are as follows: ITR, inverted terminal repeat; HA, homology arm; CMV, cytomegalovirus promoter; PAM, protospacer adjacent motif. (B) Experimental workflow for generating striatal neurons from human dermal fibroblasts. AAV donor was added to cells immediately after RNP nucleofection. Abbreviations are as follows: Aph, aphidicolin; dox, doxycycline; ICC, immunocytochemistry. (C) Frequency of targeted integration into the DARPP-32 gene in human dermal fibroblasts following delivery of plasmid donor (800 ng) and Cas9–sgRNA expression vector (800 ng) or AAV donor (MOI = 500 000) and RNP (300 pmol), as determined by digital droplet PCR. All cells were treated with 2 μg/ml of aphidicolin and 1 μM Scr7. Values are means (n = 3). (D) ICC analysis of human dermal fibroblasts after 55 days of neural differentiation. Images were captured using identical exposure conditions. Scale bar, 50 μm.
Figure 4. AAV-RNP-mediated knock-in of EGFP into the human DARPP-32 locus enables induced striatal neurons to be visualized via EGFP fluorescence. (A) Cartoon representation of the strategy used to tag the human DARPP-32 gene with EGFP. Lightning bolt indicates approximate position of the RNP cleavage site. The sgRNA target site in the DARPP-32 gene is shown. Abbreviations are as follows: ITR, inverted terminal repeat; HA, homology arm; CMV, cytomegalovirus promoter; PAM, protospacer adjacent motif. (B) Experimental workflow for generating striatal neurons from human dermal fibroblasts. AAV donor was added to cells immediately after RNP nucleofection. Abbreviations are as follows: Aph, aphidicolin; dox, doxycycline; ICC, immunocytochemistry. (C) Frequency of targeted integration into the DARPP-32 gene in human dermal fibroblasts following delivery of plasmid donor (800 ng) and Cas9–sgRNA expression vector (800 ng) or AAV donor (MOI = 500 000) and RNP (300 pmol), as determined by digital droplet PCR. All cells were treated with 2 μg/ml of aphidicolin and 1 μM Scr7. Values are means (n = 3). (D) ICC analysis of human dermal fibroblasts after 55 days of neural differentiation. Images were captured using identical exposure conditions. Scale bar, 50 μm.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 76 references

Cited by

See all 92

Metadata

Authors
Gaj, T., Staahl, B. T., Rodrigues, G. M. C., Limsirichai, P., Ekman, F. K., Doudna, J. A., & Schaffer, D. V.
Affiliations
  • University of California, Berkeley (US)
  • University of Lisbon (PT)
  • Howard Hughes Medical Institute (US)
Corresponding author
  • Gaj, Thomas
  • Staahl, Brett T.
  • Doudna, Jennifer A.
  • Schaffer, David V.
Venue
Nucleic Acids Research
Published
2017-03-02
Volume
45
Issue
11
Pages
e98-e98
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2594121715
Cited by
89
References
76
Citations by year
2026: 4 · 2025: 4 · 2024: 12 · 2023: 6 · 2022: 8 · 2021: 13 · 2020: 9 · 2019: 17 · 2018: 10 · 2017: 5
FWCI
4.58
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion, other-oa)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • F. Hoffmann-La Roche
  • Innovative Genomics Institute
  • National Institutes of Health
  • University of California, San Francisco
  • Fundação para a Ciência e a Tecnologia (SFRH/BD/89374/2012)
  • National Eye Institute (R01EY022975)
  • National Institute of General Medical Sciences (F32GM113446)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Keywords
homology-directed repair, CRISPR/Cas9 ribonucleoprotein, adeno-associated virus vectors, gene knock-in, striatal neurons, fibroblast-to-neuron conversion, single guide RNA
MeSH terms
CRISPR-Associated Protein 9, Dependovirus, Bacterial Proteins, Base Sequence, Cell Differentiation, Endonucleases, Fibroblasts, Genetic Engineering, Genetic Vectors, Humans, Neurons, Sequence Homology, Nucleic Acid, Genome, Human, Gene Knock-In Techniques, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery. https://app.cochat.ai/papers/10.1093/nar/gkx154
The paper
Gaj, T., Staahl, B. T., Rodrigues, G. M. C., Limsirichai, P., Ekman, F. K., Doudna, J. A., & Schaffer, D. V. (2017). Targeted gene knock-in by homology-directed genome editing using Cas9 ribonucleoprotein and AAV donor delivery. Nucleic Acids Research. https://doi.org/10.1093/nar/gkx154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.